InvestSMART

Podcasts & Videos

Subscribe to our Free Insights Newsletter today

IPO Watch: Credit Clear off to a flyer

Credit Clear's share price is up nearly 150 per cent since its ASX debut last week. Alex Gluyas catches up with the company's Chairman, Gerd Schenkel, to discuss the opportunity COVID has provided as debt ledgers increase, the backlog of debt in the business community, and how fintechs are disrupting traditional payment methods.

05 Nov 2020
·
Article comments

IPO Watch: MyDeal rides ASX's e-commerce wave

Following its recent listing on the ASX, Alex Gluyas speaks with the CEO of MyDeal, Sean Senvirtne, about the timing of its IPO after being delayed earlier in the year, the belief that MyDeal can replicate the success of other e-commerce stocks, and the expansion of its private label products which offer superior margins.

29 Oct 2020
·
Article comments

Redbubble continues to soar

With its share price up over 400 per cent year to date, Alex Gluyas catches up with the founder and CEO of Redbubble, Martin Hosking to discuss his reappointment to the top job in February, what's behind the company's huge growth this year, and what investors should look out for in the short-term.

20 Oct 2020
·
Article comments

IPO Watch: Zebit – 'Amazon for the under-served meets Afterpay'

Ahead of its listing on the ASX, Alex Gluyas catches up with the CEO of Zebit, Marc Schneider, who explains the company's unique e-commerce platform with a built-in buy-now-pay-later offering, how it's managing the risk of serving credit-challenged customers in the US, and why it's protected from the crowded US buy-now-pay-later space.

13 Oct 2020
·
Article comments

BWX rides the shift to natural beauty products

With demand growing for its natural beauty products, Alex Gluyas speaks with the CEO of BWX, Dave Fenlon, to discuss the company's goal of moving all manufacturing of its brands to Australia, its new manufacturing and distribution centre in Melbourne and how its Sukin brand is driving sales growth.

03 Sep 2020
·
Article comments

IntelliHR catches COVID tsunami when paddling for a wave

With human resources teams unable to physically connect with employees during COVID lockdowns, IntelliHR has seen demand for its staff management technology grow faster than ever. After recently attracting the attention of tech investor Bevan Slattery, Alex Gluyas speaks with IntelliHR CEO, Rob Bromage, who explains the opportunity COVID has provided: "For the last five years, we've been working really hard and paddling out for a big wave and along has come a tsunami."

27 Aug 2020
·
Article comments

Australian property market's great escape

Alex Gluyas speaks with the CEO of REA Group, Owen Wilson, about the year that has been in Australia's property market, from the Hayne Royal Commission's impact, the signs of recovery earlier this year and then the onset of COVID, and his thoughts on why the property market might escape in better condition than first thought.

20 Aug 2020
·
Article comments

Earnings season tracking better than expected

This week on Talking Finance, Alex Gluyas is joined by Professor of Infectious Diseases at ANU's Medical School, Professor Peter Collignon, for a global discussion on all things COVID, including how safe Russia's rushed vaccine is, Sweden's herd immunity strategy and why Australia needs to learn how to live with the virus, while Portfolio Manager at Tribeca Investment Partners, Jun Bei Liu, gives her take on earnings season so far and what's driven the Nasdaq and S&P 500 to record highs. EY Oceania Chief Economist, Jo Masters, explains why Australia's economic fundamentals place it in better shape than most nations to get through the current downturn and Political Editor at The New Daily, Josh Butler, shares his thoughts on Victoria's hotel quarantine inquiry and China's latest curveball to Australia's wine industry.

19 Aug 2020
·
Article comments

4DMedical: Taking lung imaging to the next level

Following its recent listing on the ASX, Alex Gluyas speaks with the founder and CEO of 4DMedical, Andreas Fouras, to discuss the company's lung imaging technology, its usefulness in detecting and managing acute respiratory distress syndrome (ARDS) in COVID patients and the process of commercialising in the US and beyond.

18 Aug 2020
·
Article comments

61 - 72 of 368 results

Page 6 of 31